A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy as well as in Combination with TERN- 101 in Noncirrhotic Adults with Presumed Non-Alcoholic Steatohepatitis (NASH)

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date1/18/23 → …